Sub-Total: $0.00
Emerging Biological Therapies for Psoriasis: Promising Efficacy of Interleukin‐17 (IL‐17) and IL‐23 Pathway Inhibitors
Complimentary
Related products
-
Advances in Blood-based Biomarkers and Disease-Modifying Anti-Amyloid Antibody Therapies for Early-Stage Alzheimer’s Disease
Read more -
Novel Therapies for Chronic Rhinosinusitis with Nasal Polyps
Read more -
Ocular Surface Disease: Pathophysiology, Evaluation, Management with Topical Agents, and Neuromodulation
Read more -
Biosimilars: Implications for Clinical Practice in Inflammatory Bowel Diseases
Read more
